357 related articles for article (PubMed ID: 2556716)
1. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.
Glaser R; Zhang HY; Yao KT; Zhu HC; Wang FX; Li GY; Wen DS; Li YP
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9524-8. PubMed ID: 2556716
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas.
Yao KT; Zhang HY; Zhu HC; Wang FX; Li GY; Wen DS; Li YP; Tsai CH; Glaser R
Int J Cancer; 1990 Jan; 45(1):83-9. PubMed ID: 2153642
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Epstein-Barr virus genome in a nasopharyngeal carcinoma epithelial tumor cell line.
Zhang HY; Yao K; Zhu HC; Glaser R
Int J Cancer; 1990 Nov; 46(5):944-9. PubMed ID: 2172173
[TBL] [Abstract][Full Text] [Related]
4. Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).
Takimoto T; Kamide M; Umeda R
Arch Otorhinolaryngol; 1984; 239(1):87-92. PubMed ID: 6318711
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
Young LS; Dawson CW; Clark D; Rupani H; Busson P; Tursz T; Johnson A; Rickinson AB
J Gen Virol; 1988 May; 69 ( Pt 5)():1051-65. PubMed ID: 2836550
[TBL] [Abstract][Full Text] [Related]
6. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
Fåhraeus R; Fu HL; Ernberg I; Finke J; Rowe M; Klein G; Falk K; Nilsson E; Yadav M; Busson P
Int J Cancer; 1988 Sep; 42(3):329-38. PubMed ID: 2843473
[TBL] [Abstract][Full Text] [Related]
7. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
[TBL] [Abstract][Full Text] [Related]
8. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.
Chen MR; Tsai CH; Wu FF; Kan SH; Yang CS; Chen JY
J Gen Virol; 1999 Feb; 80 ( Pt 2)():447-455. PubMed ID: 10073707
[TBL] [Abstract][Full Text] [Related]
9. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx.
Klein G; Giovanella BC; Lindahl T; Fialkow PJ; Singh S; Stehlin JS
Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4737-41. PubMed ID: 4373728
[TBL] [Abstract][Full Text] [Related]
10. Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo.
Sheu LF; Chen A; Meng CL; Ho KC; Lee WH; Leu FJ; Chao CF
J Pathol; 1996 Nov; 180(3):243-8. PubMed ID: 8958799
[TBL] [Abstract][Full Text] [Related]
11. Establishment of an Epstein-Barr virus (EBV) genome-positive subline of Ramos (Ramos/NPC) following infection of Ramos with nasopharyngeal carcinoma (NPC)-derived EBV.
Takimoto T; Sato H; Ogura H; Miyazaki T
Auris Nasus Larynx; 1987; 14(2):87-92. PubMed ID: 2835030
[TBL] [Abstract][Full Text] [Related]
12. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
[TBL] [Abstract][Full Text] [Related]
13. STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro.
Lui VW; Wong EY; Ho Y; Hong B; Wong SC; Tao Q; Choi GC; Au TC; Ho K; Yau DM; Ma BB; Hui EP; Chan AS; Tsang CM; Tsao SW; Grandis JR; Chan AT
Int J Cancer; 2009 Oct; 125(8):1884-93. PubMed ID: 19588483
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx.
Huang DP; Ho JH; Poon YF; Chew EC; Saw D; Lui M; Li CL; Mak LS; Lai SH; Lau WH
Int J Cancer; 1980 Aug; 26(2):127-32. PubMed ID: 6259064
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas.
Busson P; Ganem G; Flores P; Mugneret F; Clausse B; Caillou B; Braham K; Wakasugi H; Lipinski M; Tursz T
Int J Cancer; 1988 Oct; 42(4):599-606. PubMed ID: 2971626
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties.
Sato H; Takimoto T; Ogura H; Tanaka J; Hatano M; Glaser R
J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175
[TBL] [Abstract][Full Text] [Related]
17. Clonal versus polyclonal Epstein-Barr virus infection in nasopharyngeal carcinoma cell lines.
Lin CT; Chen W; Hsu MM; Dee AN
Lab Invest; 1997 Jun; 76(6):793-8. PubMed ID: 9194855
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids.
Staczek J; Steplewski Z; Weinmann R; Klein G; Koprowski H
J Cell Physiol; 1981 Jun; 107(3):391-8. PubMed ID: 6265479
[TBL] [Abstract][Full Text] [Related]
19. Immunofluorescence and electron microscopic investigations of epithelial hybrid cells derived from nasopharyngeal carcinoma (NPC-KT).
Takimoto T; Morishita K; Ishiguro H; Umeda R
Auris Nasus Larynx; 1985; 12(1):37-45. PubMed ID: 2994615
[TBL] [Abstract][Full Text] [Related]
20. [The expression of HLA, Epstein-Barr virus nuclear antigen and the infiltration of T lymphocyte subsets in nasopharyngeal biopsy tissues].
Chen X; Cai Y; Sun N
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(1):6-9. PubMed ID: 8031607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
